Synaptics SYNA 深 滬
已收盤 07-31 16:00:00 美东时间
107.32
-1.530
-1.41%
華盛通- 最 高112.92
- 今 開112.605
- 成交量 86.62万股
- 最 低 106.96
- 昨 收 108.85
- 總市值 41.92亿
- 52周最高 149.11
- 市盈率 靜 --
- 換手率 2.22%
- 52周最低 58.28
- 委 比 -7.27%
- 總股本 3906.27万
- 歷史最高 299.39
- 量 比 1.34
- 振 幅 5.48%
- 歷史最低 21.97
- 每 手 1
- 風險率 23.84%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 富国银行上调亚马逊目标价从313美元升至322美元；潜在涨幅370.99%！HC Wainwright上调Greenwich LifeSciences目标价至69美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Greenwich LifeSciences"买入"评级，目标价从50美元升至69美元；高盛：维持Taysha Gene Therapies"买入"评级，目标价从11美元升至13美元
07-22 11:35
Chip industry lead time continues to accelerate, pricing rises, Susquehanna says
The lead time for the semiconductor industry continued to accelerate in June, notable even as prices rose, investment firm Susquehanna said. Lead times saw their largest monthly increase in the curren...
07-20 22:41
Synaptics to Release Fourth Quarter and Full Year Fiscal 2026 Results on August 6, 2026
Synaptics announced it will release its fiscal 2026 fourth-quarter and full-year financial results on August 6, 2026, after market close. Due to its pending transaction with onsemi, it will not host a conference call or provide a financial outlook. The press release will be available on its investor website. Synaptics is a leader in AI at the Edge, offering innovative embedded compute, wireless connectivity, and sensing solutions.
07-15 21:07
onsemi to divest two manufacturing sites
onsemi (ON) has signed definitive agreements to sell two manufacturing facilities as part of its ongoing Fab Right strategy aimed at optimizing its manufacturing cost structure and supporting sustaine...
07-07 19:08
美股大行评级 | 潜在涨幅392.61%！Chardan Capital维持EyePoint"买入"评级，上调目标价至65美元
今日重点评级关注：Chardan Capital：维持EyePoint"买入"评级，目标价从29美元升至65美元；康托·菲茨杰拉德：维持Hyperliquid Strategies"超配"评级，目标价从8美元升至18.4美元
07-02 18:41
美股大行评级 | 康托·菲茨杰拉德大幅上调AMD、英特尔、迈威尔科技、美光、西部数据目标价！Applied、INIO、LFTO、Quantinuum获多家大行首予买入评级
今日重点评级关注：Evercore ISI集团：维持ProQR Therapeutics"跑赢大市"评级，目标价从5美元升至6美元；摩根士丹利：维持霍尼韦尔"标配"评级，目标价从245美元升至490美元
06-30 10:14
美股大行评级 | 潜在涨幅90.66%！Tango Therapeutics获杰富瑞升目标价至60美元，上调至"买入"评级
今日重点评级关注：杰富瑞：上调Tango Therapeutics评级至"买入"，目标价从27美元升至60美元；Susquehanna：维持安森美半导体"积极"评级，目标价从120美元升至140美元
06-29 15:49
